These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 22086376)

  • 21. [Oral anticoagulation with vitamin K antagonists].
    Alberio L
    Ther Umsch; 2003 Jan; 60(1):5-9. PubMed ID: 12638470
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Subtherapeutic oral anticoagulant therapy: frequency and risk factors.
    Rombouts EK; Rosendaal FR; van der Meer FJ
    Thromb Haemost; 2009 Mar; 101(3):552-6. PubMed ID: 19277419
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Anticoagulation in patients with heart valve replacement in pregnancy].
    Harenberg J
    Z Kardiol; 1998; 87 Suppl 4():63-7. PubMed ID: 9857469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Anticoagulation by oral treatment with vitamin K antagonists].
    Kemkes-Matthes B
    Hamostaseologie; 2008 Dec; 28(5):421-7. PubMed ID: 19132171
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fibrinogen Aalpha312 and Bbeta448 polymorphisms are not related to bleeding during oral vitamin K-antagonist treatment.
    Garcia AA; van der Hoeven NV; Boellaard TN; van der Heijden JF; Groot AP; Reitsma PH
    Thromb Haemost; 2007 Apr; 97(4):676-8. PubMed ID: 17393034
    [No Abstract]   [Full Text] [Related]  

  • 27. Bridging with enoxaparin using a half-therapeutic dose regimen: safety and efficacy.
    Klamroth R; Gottstein S; Essers E; Landgraf H
    Vasa; 2010 Aug; 39(3):243-8. PubMed ID: 20737383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bridging anticoagulation for patients on long-term vitamin-K-antagonists. A prospective 1 year registry of 311 episodes.
    Halbritter KM; Wawer A; Beyer J; Oettler W; Schellong SM
    J Thromb Haemost; 2005 Dec; 3(12):2823-5. PubMed ID: 16359528
    [No Abstract]   [Full Text] [Related]  

  • 29. "Bridging" therapy in patients on long-term vitamin K antagonist treatment: a yet unsolved issue.
    Baudo F
    Intern Emerg Med; 2006; 1(2):94-5. PubMed ID: 17111780
    [No Abstract]   [Full Text] [Related]  

  • 30. Anticoagulants: the state of the art.
    Gallus AS
    Aust Fam Physician; 1982 Jan; 11(1):14-22. PubMed ID: 7065989
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vitamin K to reverse the anticoagulant effect of vitamin K antagonists: can you teach an old dog new tricks?
    Douketis JD; Spyropoulos AC
    J Thromb Haemost; 2010 Mar; 8(3):496-8. PubMed ID: 20040039
    [No Abstract]   [Full Text] [Related]  

  • 32. [Long-term oral anticoagulation. Self monitoring optimizes vitamin K antagonist therapy].
    MMW Fortschr Med; 2014 Nov; 156(20):79. PubMed ID: 25543379
    [No Abstract]   [Full Text] [Related]  

  • 33. The management of coumarin-induced over-anticoagulation Annotation.
    Makris M; Watson HG
    Br J Haematol; 2001 Aug; 114(2):271-80. PubMed ID: 11529844
    [No Abstract]   [Full Text] [Related]  

  • 34. [Is anticoagulation with heparins in phenprocoumon treated patients safe during operations?].
    Hoppe UC
    Dtsch Med Wochenschr; 2002 Nov; 127(44):2345. PubMed ID: 12410442
    [No Abstract]   [Full Text] [Related]  

  • 35. Can oral vitamin K before elective surgery substitute for preoperative heparin bridging in patients on vitamin K antagonists?
    Steib A; Barre J; Mertes M; Morel MH; Nathan N; Ozier Y; Treger M; Samama CM
    J Thromb Haemost; 2010 Mar; 8(3):499-503. PubMed ID: 19912513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phenprocoumon and acenocoumarol treatment in paediatric patients.
    Spoor N; Smiers FJ; van der Meer FJ; Hutten BA; van Ommen CH
    Thromb Haemost; 2012 Dec; 108(6):1238-41. PubMed ID: 23014894
    [No Abstract]   [Full Text] [Related]  

  • 37. Patients requiring interruption of long-term oral anticoagulant therapy: the use of fixed sub-therapeutic doses of low-molecular-weight heparin.
    Malato A; Saccullo G; Lo Coco L; Caramazza D; Abbene I; Pizzo G; Casuccio A; Siragusa S
    J Thromb Haemost; 2010 Jan; 8(1):107-13. PubMed ID: 19817996
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of anticoagulation before and after elective surgery.
    Kearon C; Hirsh J
    N Engl J Med; 1997 May; 336(21):1506-11. PubMed ID: 9154771
    [No Abstract]   [Full Text] [Related]  

  • 39. Outpatient management of oral vitamin K antagonist therapy: defining and measuring high-quality management.
    Phillips KW; Ansell J
    Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):57-70. PubMed ID: 18095907
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Perioperative bridging with fondaparinux in a woman with antithrombin deficiency.
    Bauersachs R; Alban S
    Thromb Haemost; 2007 Mar; 97(3):498-9. PubMed ID: 17334522
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.